Breaking: Class Action Lawsuit Filed Against CVS Health, Caremark, Aetna to Recoup DIR Fees
Drug Topics
SEPTEMBER 27, 2023
The class action lawsuit against CVS Health, Caremark, and Aetna was announced earlier today.
Wed.Sep 27, 2023
252 
Pharmacies and Labs Must Work Together to Accelerate Test and Treat Opportunities, Enhance Patient Care Equity, Improve Health Outcomes
Pharmacy Times
SEPTEMBER 27, 2023
Working together, pharmacies and labs can answer the call to align and back legislation that supports pharmacists as providers, help patients gain greater access to affordable care, and reap the benefits of improved health outcomes while growing business revenue.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Opioid Use Disorder Medication Initiation After ED Visits for Overdose Remains Low
Drug Topics
SEPTEMBER 27, 2023
A study from the University of Michigan found that only 1 in 6 emergency department visits for an opioid overdose in the United States result in a prescription for buprenorphine, methadone, or extended-release naltrexone.
STAT+: The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she’s been edged out of the story
STAT
SEPTEMBER 27, 2023
On a mild May day in 1993, about 60 scientists and doctors gathered on a lawn in Copenhagen to commemorate the first International Symposium on GLP-1, the hormone that decades later would become the basis for highly effective diabetes and obesity drugs like Ozempic and Wegovy. The meeting was a scientific showcase of all the leading experts in the nascent field.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
How Amazon's $4B investment in AI company Anthropic impacts healthcare
Fierce Healthcare
SEPTEMBER 27, 2023
Amazon announced this week that it would invest up to $4 billion in artificial intelligence company Anthropic as the AI arms race heats up. | Amazon announced this week that it would invest up to $4 billion in artificial intelligence company Anthropic as the AI arms race heats up. The collaboration introduces more competition and more options for healthcare teams looking to innovate using different approaches or to get more tactical with their AI strategy, one health IT expert said.
Gene therapy death was caused by an unknown risk of the virus used, study suggests
STAT
SEPTEMBER 27, 2023
Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation. Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: Over-the-counter Sudafed doesn’t work. Neither does our system for evaluating older drugs
STAT
SEPTEMBER 27, 2023
You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.
Large Review Suggests IVIG is Effective for Neurological Diseases Following COVID-19 Infection
Pharmacy Times
SEPTEMBER 27, 2023
Intravenous immunoglobulin found to provide fast and long-lasting relief for COVID-19-related neurological conditions, although investigators are still uncovering the pathology of many of these conditions.
STAT+: Biogen shutters digital health group, nixes Apple study, as part of cost cuts
STAT
SEPTEMBER 27, 2023
Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned. Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.
Newer primary care disrupters constrain already limited supply of clinical providers, new analysis finds
Fierce Healthcare
SEPTEMBER 27, 2023
As new primary care models, including retail health clinics, continue to scale, the national supply of clinical providers will become even more constrained. | As new primary care models, including retail health clinics, continue to scale, the national supply of clinical providers will become even more constrained. For health systems, hospitals and medical groups, competition for the shrinking pool of nurses and doctors will intensify, according to a new analysis.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: U.S. government’s next-gen Covid effort gives small biotech up to $433 million
STAT
SEPTEMBER 27, 2023
The U.S. government’s “Project Nextgen,” its effort to accelerate and streamline the rapid development of the next generation of Covid vaccines and treatments, said Wednesday that it would give a small biotechnology firm, Gritstone bio, up to $433 million to conduct a 10,000-volunteer clinical trial testing a new approach to creating a vaccine.
Wheel doubles down on virtual care investment, rolls out enhanced platform for payers, retailers and pharma
Fierce Healthcare
SEPTEMBER 27, 2023
Big players continue to make hefty investments in health tech—look no further than Amazon expanding its virtual clinic to all 50 states and the planned $3 billion merger between digital wellness co | Health tech company Wheel has been building for the next evolution of virtual care with an eye toward working with large enterprises, health plans, pharma and nontraditional players like retailers.
Children of color and from low-income families disproportionately harmed by toxic chemicals, study finds
STAT
SEPTEMBER 27, 2023
Children are often exposed to harmful chemicals in air, water, soil, food, food packaging, and plastics. However, low-income children and children of color are disproportionately impacted by these exposures, according to the authors of a study that examines disparities in neurotoxic exposures and their harmful effects on children by race, ethnicity, and economic status.
Yoga Could be an Effective Natural Treatment for Individuals with Heart Failure
Pharmacy Times
SEPTEMBER 27, 2023
Routine yoga therapy has shown endurance, strength, balance, symptom stability and quality of life improvements in individuals with heart failure.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: FDA advisers vote overwhelmingly against ALS treatment from BrainStorm
STAT
SEPTEMBER 27, 2023
A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval. After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on con
New Paper Urges CMS to Reconsider Anti-Obesity Medications as Treatment for Chronic Disease
Pharmacy Times
SEPTEMBER 27, 2023
Current federal statutes exclude anti-obesity medications for coverage when used for anorexia, weight loss, or weight gain.
STAT+: Bubble bursts: 2021 health tech IPOs and SPACs lose value, burn cash
STAT
SEPTEMBER 27, 2023
In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud. Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt.
1930s racist mortgage system embedded healthcare inequities that linger in Medicaid: study
Fierce Healthcare
SEPTEMBER 27, 2023
Structural racism encompassing groups, not bigotry targeting individuals, drives much of the healthcare inequity in the U.S., according to a study in Health Affairs. | The residual effects of a 1930s racist mortgage program are still being felt. The expansion of Medicaid coverage under the Affordable Care Act helped address the problem to some extent, but not all states elected to take advantage of that opportunity.
Octopus tentacles inspired a new drug delivery patch that sticks to the inside of your cheek
STAT
SEPTEMBER 27, 2023
The story of the latest development in drug administration technology — a mouth patch that can deliver peptides and proteins without injection — begins with Chinese fondue. Researcher Zhi Luo, the lead author of a new paper detailing the patch development published in Science Translational Medicine, was enjoying the spicy fondue dish when he found himself fascinated by Sichuan peppercorns.
Pharmacists, Staff Can Utilize Workflow Wednesdays to Enhance Their Skill Set
Drug Topics
SEPTEMBER 27, 2023
A Q&A with Tiffany Capps, CPhT, pharmacy operations manager at Galloway-Sands Pharmacy in North Carolina and marketing communications manager at CPESN Networks.
Opinion: Paxlovid is not fully accessible to those who need it most: the immunocompromised
STAT
SEPTEMBER 27, 2023
The pandemic is over for most of the world. But for the 2.7% of adults in the United States who are immunocompromised , it isn’t. I’m one of them. As we are all increasingly expected to return to pre-pandemic routines, including traveling abroad, those of us with a weakened immune system are attempting to be proactive — to plan ahead for possible illness.
FTC accuses Amazon of illegally maintaining monopoly power
Drug Store News
SEPTEMBER 27, 2023
The FTC and 17 state attorneys general sued Amazon.com, alleging that the online retail and technology company is a monopolist that uses interlocking anticompetitive and unfair strategies to maintain its monopoly power illegally.
As Viatris seeks growth in eye care, its Ocuphire-partnered dilation drop Ryzumvi wins FDA nod
Fierce Pharma
SEPTEMBER 27, 2023
Viatris just notched a win on its quest to reach $1 billion in eye care sales by 2028. | The FDA on Wednesday approved Viatris and Ocuphire’s Ryzumvi, also known as phentolamine ophthalmic solution, to treat pharmacologically-induced mydriasis, or dilation of the pupils. The partners plan to make Ryzumvi available in the U.S. in the first half of 2024.
CVS pharmacists in Kansas City stage walkouts
Drug Store News
SEPTEMBER 27, 2023
CVS Health is focused on addressing the concerns raised by its pharmacists so it can continue to deliver the high-quality care its patients depend on, the retailer said.
'We can't forget about this': As chemotherapy shortage ebbs and flows, attention shifts to long-term solutions
Fierce Pharma
SEPTEMBER 27, 2023
It’s been about 10 months since FDA inspectors rebuked a | As some cancer centers struggle to secure access to key platinum-based chemotherapies, a national spotlight gives the issue newfound political importance. But will this be a turning point for the recurrent shortage issue? ASCO's Julie Gralow, M.D., certainly hopes so.
Watch DSN: Walgreens’ May touches on importance of mental health resources
Drug Store News
SEPTEMBER 27, 2023
Holly May, executive vice president and global chief human resources officer at Walgreens Boots Alliance, discusses the company’s partnership with Mental Health America.
Centene to lay off 2,000 employees
Fierce Healthcare
SEPTEMBER 27, 2023
St. Louis-based health insurer Centene is laying off approximately 2,000 workers, or about 3% of its total workforce. | Health insurer Centene is laying off 3% of its workforce, but gave sparse details on the decision.
2024 Technology Trends
Drug Topics
SEPTEMBER 27, 2023
As we look ahead to 2024, the pharmacy landscape is poised to undergo transformative changes driven by technology.
Federal judge sides with LCMC Health, Louisiana over FTC's challenge to 3-hospital purchase
Fierce Healthcare
SEPTEMBER 27, 2023
A U.S. | The case was a test of whether a state's Certificate of Public Advantage exempted a health system from submitting to federal regulatory review.
Women in Science: ScaleReady’s Jenny Stjernberg and her fervent passion for cell and gene therapies
Outsourcing Pharma
SEPTEMBER 27, 2023
At Advanced Therapies Europe 2023, BioPharma Reporter caught up with ScaleReady's Jenny Stjernberg to discuss her work at the biotech company, her journey from academia to commercial and female representation in the cell and gene therapies industry.
Highlights from APEX 2023 Saturday Night Banquet
Drug Topics
SEPTEMBER 27, 2023
APEX 2024 will be here before you know it. Watch pharmacists, exhibitors and guests dance the night away during the Saturday night banquet.
Study Results Indicate Purpose in Life Declines with Emergence of Cognitive Impairment
Pharmacy Times
SEPTEMBER 27, 2023
Maintaining a purpose in life has the potential to reduce apathy related to dementia and cognitive decline.
Walgreens study: Medication adherence is important in rheumatoid arthritis treatment
Drug Store News
SEPTEMBER 27, 2023
Patients who are adherent to their non-infused RA biologic medication are more likely to have lower medical costs, said a study by AllianceRx Walgreens Pharmacy and Walgreens.
In Emgality patent case against Teva, Lilly wins reversal of $177M verdict
Fierce Pharma
SEPTEMBER 27, 2023
A U.S. judge has sided with Lilly, overturning a $176.5M jury verdict awarded to Teva in a patent infringement squabble over competing migraine drugs.
Let's personalize your content